PFBT
DNA icon

Parkside Financial Bank & Trust’s Ginkgo Bioworks DNA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16
Closed -$1.05K – 2048
2023
Q4 		$1.05K Buy
+16
New +$980 ﹤0.01% 1609
2023
Q1 		– Sell
-6
Closed -$395 – 2040
2022
Q4 		$395 Buy
+6
New +$552 ﹤0.01% 1928

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's DNA Position: Q1 2024 in Review

Parkside Financial Bank & Trust sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 16 shares — an estimated $1.05K sold.

Parkside Financial Bank & Trust first reported a position in DNA in Q4 2022 and held it in 2 quarters. The position peaked at $1.05K in Q4 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Parkside Financial Bank & Trust reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 16 Ginkgo Bioworks shares in Q1 2024, an estimated $1.05K.
  • Parkside Financial Bank & Trust first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 2 quarters.
  • Parkside Financial Bank & Trust's Ginkgo Bioworks position peaked at $1.05K in Q4 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2024, filed 1 May 2024.